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We present a 53-year-old female suffering from familial
adenomatous polyposis, who was found to have a positive
nodus,lateraltothehilusoftheleftlung,onroutineFDG-PET
scan. This lesion was found to be a sclerosing hemangioma.
We found an aberrant b-catenin expression on immunohis-
tochemical staining, suggesting that sclerosing hemangioma
and familial adenomatous polyposis share the same patho-
physiology. It is important to be aware of the association of
familial adenomatous polyposis and sclerosing hemangioma.
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S
clerosing hemangioma is a rare, but presumably,
benign lung tumor, believed to originate from
pneumocyte Type II cells,
1 which was first as such
described by Liebow and Hubbell in 1956.
2 It is a
rare lung tumor, probably accounting for approxi-
mately 3 to 5 percent of benign lung lesions. Case
series suggest that females are mainly affected, with a
reported median age of 46 years at presentation.
3,4
Sclerosing hemangiomas often are asymptomatic and
are usually an unexpected finding on routine imag-
ing studies. The lesions are well circumscribed and
do not invade the adjacent normal lung parenchyma.
The diagnosis is made on the basis of histologic
examination. Sclerosing hemangiomas are composed
of round cells with bland nuclei and pale to clear
Supported by a NWO-VIDI grant to Joost P. H. Drenth, M.D.,
Ph.D.
Reprints are not available.
Correspondence to: Joost P. H. Drenth, M.D., Ph.D., Department
of Medicine, Division of Gastroenterology and Hepatology,
Radboud University Nijmegen Medical Center, P.O. Box 9101
6500 HB, Nijmegen, The Netherlands, e-mail: JoostPHDrenth@CS.
com
Dis Colon Rectum 2007; 50: 1987–1991
DOI: 10.1007/s10350-006-0862-1
* The American Society of Colon and Rectal Surgeons
Published online: 27 April 2007
1987cytoplasm, but also papillary structures, with cuboi-
dal cells lining them, are present. Sclerosing heman-
giomas can exhibit four described patterns on
histologic presentation: papillary, sclerotic, hemor-
rhagic, and solid, and all patterns can be present or
absent within lesions.
4
Little is known of the natural course, prognosis,
and associated risk factors of sclerosing hemangio-
ma. A recent case described the identification of a
sclerosing hemangioma in a patient with attenuated
familial adenomatous polyposis (FAP).
5 FAP is a rare
genetic disease (OMIM #175100) characterized by
the development of literally hundreds to thousands
of adenomatous polyps in the colon, which, if left
untreated, lead to cancer at a young age.
6 We wish
to report the unexpected discovery of a sclerosing
Figure 1. A. Fluorodeoxyglucose on positron emission tomography (FDG-PET) showing a bright spot at the left hilum of
the lung with a maximal SUV of 1.6. B. Chest x-ray showing a well-rounded hilary lesion of the left lung. There is a close
lesion situated at approximately the same place as is the spot found on the FDG-PETscan. C. Contrast-enhanced CTat
lung window settings, showing a sharply demarcated lesion with a diameter of 2.1 cm located in the left hemithorax. D.
Chest x-ray after surgical removal of the pneumocytoma.
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deoxyglucose (FDG) on positron emission tomog-
raphy (PET) in a patient suffering from FAP.
REPORT OF A CASE
Clinical Evaluation
A 53-year-old female was seen at our outpatient
clinic because of follow-up of FAP. Her medical
history revealed a total colectomy and insertion of an
ileostoma in 1986 because of FAP. The germline
mutation was localized on exon 13 of the APC gene
(C1660 T; Arg 554 X). Routine endoscopy of duode-
num revealed a number of adenomatous polyps,
mainly located around the ampulla of Vater. Her
father had died at age 60 years because of lung
cancer. She complained of a persistent, dry cough,
but denied smoking. No abnormalities were found
on physical examination. Because of a protocol for
the follow-up of duodenal adenomas, a FDG-PET
scan was made. Whole-body PET, 30 minutes after
the intravenous injection of 250 MBq Fluor-18-FDG,
revealed a small hot spot located at the hilus of the
left lung (Fig. 1A). Although the uptake of the entire
mass was little over background uptake (standard
uptake value (SUV) 1.6), this did not rule out a
malignancy. A chest x-ray and contrast-enhanced CT
revealed a single circumscriptive lesion, with a
diameter of 2.1 cm, situated in the left lung close to
the hilus (Fig. 1B and C). There were no enlarged
lymph nodes. Because a malignant lung tumor could
not be excluded on basis of the available imaging
data and because of her underlying FAP, we
proceeded to a left-sided thoracotomy with excision
of the tumor followed.
Pathologic Examination
On gross examination, a well-circumscribed,
solid, subpleural tumor was found with a greatest
dimension of 2 cm. Histologically, the lesion had a
mixed papillary, solid and sclerotic pattern of two
cell types: cuboidal surface cells, and round stromal
cells. Focal clusters of foamy macrophages and
cholesterol clefts were seen. Immunohistochemical
studies showed expression of cytokeratin 7 in the
surface cells (Fig. 2A). Thyroid transcription factor 1
was positive in both surface cells as well as in
s t r o m a lc e l l s .T h et u m o rw a sclassified as a scleros-
ing hemangioma. Additional immunohistochemical
staining for b-catenin showed an aberrant expres-
sion in the cytoplasm and in the nucleus of both the
surface and round cells (Fig. 2B).
DISCUSSION
This is a case report of a solitary pulmonary lesion
discovered by FDG-PET in a patient with FAP and
found to be a sclerosing hemangioma on pathologic
examination. Most manifestations of FAP are restrict-
ed to the gastrointestinal tract and include duodenal
and colonic cancer as well as fundic gland polyposis.
In a variant of FAP, Gardner_s syndrome, patients not
only have colonic polyps, but also extracolonic
manifestations, such as desmoid tumors, osteomas,
epidermoid cysts, various soft tissue tumors, and a
Figure 2. A. Histology of sclerosing hemangioma, papil-
lary pattern with sclerotic areas (hematoxylin and eosin
stain; 5). B. Immunohistochemical stain for b-catenin
(20). A normal expression at cell membrane was
displayed in the adjacent bronchusepithelium (most left
in photo), whereas an aberrant expression was seen in
nucleus and cytoplasm of both the surface and round
cells in sclerosing hemangioma.
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7 Our patient did
not have any extraintestinal manifestations of her
FAP until she presented with a sclerosing hemangi-
oma. We were able to identify a single, comparable
case from the literature. This 54-year-old, asymptom-
atic female affected with attenuated familial adeno-
matous polyposis (AFAP) presented with a left lower
lobe mass on chest x-ray examination on a routine
health checkup. CT and magnetic resonance imaging
studies revealed a sharply demarcated lesion with a
maximal diameter of 3.6 cm without evidence for
metastases. The lesion had a slightly increased FDG
uptake ratio of 1.8 on PET. A surgical enucleation
followed and pathologic examination was compati-
ble for sclerosing hemangioma.
8
In the majority of cases, a sclerosing hemangioma
is asymptomatic and is usually found only after
routine imaging studies for other unrelated reasons.
In a clinical series, 11 percent of patients presented
with hemoptysis and 9 percent with cough.
3 In a
retrospective series of 100 cases, there was no
evidence for bilateral tumors or widespread metasta-
sized disease, corroborating with the benign nature
of the tumor.
3 On the other hand, there was one
patient with regional lymph node metastases, and
there have been reports with multiple sclerosing
hemangioma lesions and lymph node metastases
implying a more malignant potential.
9,10 This might
corroborate with the monoclonality of the cells
within the lesion.
11 This finding suggests a neoplastic
growth pattern, but invasion of normal lung paren-
chyma has not been described.
12 The prognosis after
surgical resection is excellent, although performing a
second surgical procedure because of local recur-
rence is necessary in a small percentage of cases.
3,4
The actual prevalence of sclerosing hemangiomas
among FAP patients is unknown, and this is most
likely caused by the relatively asymptomatic nature
of the disease. Although the co-occurrence may have
arisen by chance, a recent report reiterates its
association and demonstrated an aberrant nuclear
and cytoplasmic expression of b-catenin in the
sclerosing hemangioma.
5 b-catenin is an extracellular
circulating protein that activates the Wnt-pathway.
Uncontrolled activation of the Wnt-pathway leads to
uncontrolled cell growth and finally to malignancy.
The aberrant staining of b-catenin of the sclerosing
hemangioma in FAP suggests that it is a part of the
clinical phenotype of FAP.
5 When abundantly avail-
able in the cell cytosol, b-catenin can induce
transcription of a number of genes, primarily in-
volved in regulating cell growth, which are thought
to play a critical role in tumorigenesis. Positive
staining for b-catenin, thus demonstrating accumula-
tion of the protein in the cell cytosol, is described in a
number of tumors, especially colorectal cancers. In
colorectal cancer, b-catenin accumulation emerges as
a result of mutation of the APC gene, which encodes
for a product that is critical for b-catenin degradation.
FAP probably arises because a dominant-negative
effect of APC gene protein products, which suggest
that it acts as a tumor-suppressor gene. APC gene
mutations have been described almost exclusively in
colorectal cancer. It is possible that somatic APC
mutations underlie the sclerosing hemangioma,
which would imply sclerosing hemangioma and
FAP share the same pathophysiology. We did not
pursue this possibility, but we found aberrant b-
catenin staining, which has not been described in
sclerosing hemangioma so far, with the exception of
one other FAP case. The aberrant b-catenin is similar
to those found in other FAP-associated tumors.
13,14
FDG-PET is well positioned to distinguish benign
from malignant lesions in the evaluation of a solitary
pulmonary nodule. A recent meta-analysisindicated that
FDG-PET has an overall median sensitivity of 97 percent
and a specificity of 78 percent in the evaluation of a
solitary pulmonary nodule.
15 In this respect, this
diagnostic approach has been shown to be more
accurate than CT. The relatively low SUV in our patient
with FAP (1.6) and another recent FAP case from the
literature (1.8) suggest that the biologic behavior of
sclerosing hemangioma in FAP may be benign because
malignant lesions are characterized by higher SUV
values.
5 We used FDG as radiopharmacon, but C-
11-choline might be an alternative for identification of
as c l e r o s i n gh e m a n g i o m aw i t hP E T .
16
CONCLUSIONS
We described the first sclerosing hemangioma
associated with true FAP, a lesion that may become
increasingly more important when more patients with
FAP are screened with modern imaging modalities.
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